Regenxbio (RGNX) Cash from Investing Activities (QoQ) (2015 - 2025)
Powered by 
Analysis
Regenxbio (RGNX) Cash from Investing Activities (QoQ) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -11.23% |
| Sep 30, 2025 | 130.11% |
| Jun 30, 2025 | -413.87% |
| Mar 31, 2025 | 11.10% |
| Dec 31, 2024 | -19.87% |
| Sep 30, 2024 | 18,852.99% |
| Jun 30, 2024 | -102.03% |
| Mar 31, 2024 | -61.20% |
| Dec 31, 2023 | -12.11% |
| Sep 30, 2023 | -29.99% |
| Jun 30, 2023 | -12.48% |
| Mar 31, 2023 | 136.31% |
| Dec 31, 2022 | -49.66% |
| Sep 30, 2022 | 5,006.85% |
| Jun 30, 2022 | 98.81% |
| Mar 31, 2022 | 58.13% |
| Dec 31, 2021 | -1,443.76% |
| Sep 30, 2021 | 106.45% |
| Jun 30, 2021 | 103.64% |
| Mar 31, 2021 | -1,951.19% |